In addition, obesity is associated with a reduction in the cognitive-enhancing effects of intranasal insulin in humans (for review, see Kullmann et al., 2016) and impairments in hippocampal glutamatergic plasticity (Fadel and Reagan, 2016). Here, INS is linked to obesity disorder.